This suggests that elevated levels of miR-664b-3p can suppress Rheb expression, thereby inhibiting downstream mTORC1 activity and reducing c-MYC-mediated metabolic reprogramming, a hallmark of cancer progression. This evidence concerns the gene MYC and cancer.